The healthcare industry could benefit from the use of 3D printing technology to customise medical devices and drugs, market analyst Frost & Sullivan have said.
Recent research by the group’s TechVision – 3D Printing for Healthcare Applications – has shown how a large number of markets have shown interest in adopting 3D printing in a drive towards more personalised medicine
More so, the research states how 3D printing can be merged with pharma practices such as continuous manufacturing (CM) to develop various dosage forms for a specific demographic. 3D printing can also be used to bring about a change in the structure of medication, making it easier for medication to be swallowed or dissolved.
